 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
|
|
|
|
Phase IV
|
|
|
|
2006-00055-18
NCT00415103
|
|
| |
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
|
|
|
|
Phase III, Phase II
|
|
|
|
Levosta-CBF-02/04
NCT00215007
|
|
| |
Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant
|
|
|
|
Phase III, Phase II
|
|
|
|
EudraCT:2005-000805-68
NCT00354120
|
|
| |
Nonmyeloablative Stem Cell Transplant in Elderly
|
|
|
|
Phase III, Phase II
|
|
|
|
012000
NCT00382759
|
|
| |
Immediate vs Deferred Empirical Antifungal Treatment With Voriconazole in Neutropenic Patients
|
|
|
|
Phase III
|
|
|
|
A1501029
NCT00150345
|
|
| |
A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-Risk Haematology Patients
|
|
|
|
Phase III
|
|
|
|
55/05
ALLG SC01, NHMRC Project Grant 331305, NCT00163722
|
|
| |
Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation
|
|
|
|
Phase III
|
|
|
|
PROGAST
NCT00180089
|
|
| |
Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Allogeneic Transplantation
|
|
|
|
Phase II, Phase I
|
|
|
|
FHCRC-1803.00
5606, NCT00068718
|
|
| |
Stem Cell Transplant for Hematologic Diseases and Renal Cell Cancer
|
|
|
|
Phase II, Phase I
|
|
|
|
H8713
NCT00058825
|
|
| |
Allogeneic Transplantation From Related Haploidentical Donors in Older Patients With Indolent Hematologic Malignancies
|
|
|
|
Phase II, Phase I
|
|
|
|
BMT124
75117, BMT124, NCT00185692, NCT00185692
|
|
